Alzheimer Disease Familial  >>  crenezumab (RG7412)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
crenezumab (RG7412) / AC Immune
ABBY, NCT01343966 / 2010-021926-37: A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease

Completed
2
448
US, Canada, Europe
MABT5102A, placebo
Genentech, Inc.
Alzheimer's Disease
02/14
02/14
BLAZE, NCT01397578 / 2010-022598-32: A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Completed
2
91
US, Europe
MABT5102A, placebo
Genentech, Inc.
Alzheimer's Disease
04/14
04/14

Download Options